JP2014520786A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520786A5 JP2014520786A5 JP2014517820A JP2014517820A JP2014520786A5 JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5 JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014517820 A JP2014517820 A JP 2014517820A JP 2014520786 A5 JP2014520786 A5 JP 2014520786A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173066.9 | 2011-07-07 | ||
| EP11173066 | 2011-07-07 | ||
| PCT/EP2012/063242 WO2013004816A1 (en) | 2011-07-07 | 2012-07-06 | Darunavir formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520786A JP2014520786A (ja) | 2014-08-25 |
| JP2014520786A5 true JP2014520786A5 (ja) | 2015-07-16 |
| JP6101260B2 JP6101260B2 (ja) | 2017-03-22 |
Family
ID=46458539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517820A Active JP6101260B2 (ja) | 2011-07-07 | 2012-07-06 | ダルナビル製剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20140142174A1 (ja) |
| EP (1) | EP2729128B1 (ja) |
| JP (1) | JP6101260B2 (ja) |
| KR (1) | KR101817991B1 (ja) |
| CN (1) | CN103841962B (ja) |
| AU (1) | AU2012280277B2 (ja) |
| BR (1) | BR112014000195A2 (ja) |
| CA (1) | CA2837539C (ja) |
| CY (1) | CY1119446T1 (ja) |
| DK (1) | DK2729128T3 (ja) |
| EA (1) | EA026588B1 (ja) |
| ES (1) | ES2598823T3 (ja) |
| HR (1) | HRP20161340T1 (ja) |
| HU (1) | HUE030341T2 (ja) |
| IL (1) | IL229700B (ja) |
| LT (1) | LT2729128T (ja) |
| MX (1) | MX341976B (ja) |
| PL (1) | PL2729128T3 (ja) |
| PT (1) | PT2729128T (ja) |
| RS (1) | RS55236B1 (ja) |
| SI (1) | SI2729128T1 (ja) |
| SM (1) | SMT201600380B (ja) |
| WO (1) | WO2013004816A1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2729130T1 (en) | 2011-07-07 | 2018-03-30 | Janssen Sciences Ireland Uc | Combined formulations of darunavir |
| MX2016002560A (es) | 2013-08-29 | 2016-10-26 | Teva Pharma | Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir. |
| JP5843986B2 (ja) * | 2014-03-25 | 2016-01-13 | アステラス製薬株式会社 | 粒状医薬組成物 |
| EP3129009A1 (en) | 2014-04-08 | 2017-02-15 | Teva Pharmaceutical Industries Ltd | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir |
| WO2016067090A1 (en) | 2014-10-26 | 2016-05-06 | King Abdullah University Of Science And Technology | Alkaloids from sponge, scaffolds for the inhibition of human immunodeficiency virus (hiv) |
| WO2019018676A1 (en) | 2017-07-20 | 2019-01-24 | Janssen Sciences Ireland Unlimited Company | COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR USE IN THE TREATMENT OF HIV |
| US20200101093A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Sciences Ireland Unlimited Company | Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV |
| WO2021180963A1 (en) | 2020-03-13 | 2021-09-16 | Janssen Sciences Ireland Unlimited Company | A protease inhibitor regimen for treating subjects infected with hiv |
| CA3172889A1 (en) | 2020-04-20 | 2021-10-28 | John Docherty | Compositions and methods for enhanced delivery of antiviral agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| EP0715618B1 (en) | 1993-08-24 | 1998-12-16 | G.D. Searle & Co. | Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| EP2336134B1 (en) | 1998-06-23 | 2016-08-31 | The United States of America, represented by the Secretary, Department of Health and Human Services | Fitness assay and methods for reducing resistance of HIV to therapy |
| TWI286476B (en) | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
| US20100190809A1 (en) * | 2007-06-25 | 2010-07-29 | Jody Firmin Voorspoels | Combination formulations |
| AR069539A1 (es) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | Avances respecto de las formulaciones de comprimidos contra el vih |
| GT200800303A (es) * | 2007-12-24 | 2009-09-18 | Combinacion anti-retroviral | |
| CA2776807C (en) * | 2009-09-17 | 2018-10-16 | Mylan Laboratories Limited | An improved process for the preparation of darunavir |
-
2012
- 2012-07-06 LT LTEP12732668.4T patent/LT2729128T/lt unknown
- 2012-07-06 JP JP2014517820A patent/JP6101260B2/ja active Active
- 2012-07-06 PT PT127326684T patent/PT2729128T/pt unknown
- 2012-07-06 RS RS20160872A patent/RS55236B1/sr unknown
- 2012-07-06 EP EP12732668.4A patent/EP2729128B1/en active Active
- 2012-07-06 HU HUE12732668A patent/HUE030341T2/en unknown
- 2012-07-06 AU AU2012280277A patent/AU2012280277B2/en active Active
- 2012-07-06 SI SI201230742A patent/SI2729128T1/sl unknown
- 2012-07-06 MX MX2013015196A patent/MX341976B/es active IP Right Grant
- 2012-07-06 BR BR112014000195A patent/BR112014000195A2/pt not_active Application Discontinuation
- 2012-07-06 WO PCT/EP2012/063242 patent/WO2013004816A1/en active Application Filing
- 2012-07-06 PL PL12732668T patent/PL2729128T3/pl unknown
- 2012-07-06 CN CN201280033515.0A patent/CN103841962B/zh active Active
- 2012-07-06 ES ES12732668.4T patent/ES2598823T3/es active Active
- 2012-07-06 US US14/131,272 patent/US20140142174A1/en not_active Abandoned
- 2012-07-06 DK DK12732668.4T patent/DK2729128T3/en active
- 2012-07-06 KR KR1020147000084A patent/KR101817991B1/ko active IP Right Grant
- 2012-07-06 EA EA201490223A patent/EA026588B1/ru unknown
- 2012-07-06 CA CA2837539A patent/CA2837539C/en active Active
-
2013
- 2013-11-28 IL IL229700A patent/IL229700B/en active IP Right Grant
-
2016
- 2016-01-07 US US14/990,621 patent/US20160113949A1/en not_active Abandoned
- 2016-10-13 HR HRP20161340TT patent/HRP20161340T1/hr unknown
- 2016-10-25 CY CY20161101073T patent/CY1119446T1/el unknown
- 2016-10-26 SM SM201600380T patent/SMT201600380B/it unknown
-
2021
- 2021-04-27 US US17/242,218 patent/US20210244749A1/en active Pending